Search results
Xenetic Biosciences, Inc. Announces Executive Leadership Transition
Morningstar· 4 days agoFRAMINGHAM, MA / ACCESSWIRE / May 22, 2024 / Xenetic Biosciences, Inc. (NASDAQ:XBIO) ("Xenetic" or the "Company"), a biopharmaceutical company focused on advancing innovative immune-oncology ...
Tyligand Bioscience Announces First Patient Dosed in Phase 1/2 Clinical Trial of TSN1611, a...
WPRI Providence· 2 days agoTyligand Bioscience, a clinical-stage biotechnology company focused on the discovery and development of innovative cancer therapies, announced that the first patient had been dosed in the Phase ...
FDA grants IND clearance for Abdera’s Phase I cancer therapy trial
Clinical Trials Arena via Yahoo Finance· 2 days agoThe US Food and Drug Administration (FDA) has granted clearance for Abdera Therapeutics'...
ASCO: J&J's radioligand spurs responses, but 4 deaths mar early results
FierceBiotech· 2 days agoJohnson & Johnson’s radiopharmaceutical spurred “profound and durable” responses, however, four...
Adolore BioTherapeutics Outlines Strategy for its Next Generation, Disease-Modifying, Non-Opioid...
The Kansas City Star· 5 days agoDevelopment program for the treatment of osteoarthritis (OA) chronic knee pain is fully funded through the first-in-human clinical study by a UG3/UH3 grant awarded by NIH/NINDS HEAL program
Endoscopic Ablation Reduces 'Hunger Hormone,' Yields Weight Loss in Early Trial
MedPage Today· 5 days agoEndoscopic gastric fundus mucosal ablation (GFMA) as a means of reducing production of the...
Here's what it's like inside the operating room when someone gets a brain implant
CNBC· 20 hours agoAs the lights dimmed in an operating room at The Mount Sinai Hospital in New York City, Dr. Joshua...
Regeneron (REGN) Announces Positive Data on Oncology Candidate
Zacks via Yahoo Finance· 2 days agoRegeneron's (REGN) REGN7075, in combination with its oncology drug Libtayo, generates anti-tumor...
Chinese-led team’s AI thyroid scan robot ‘close’ to doctors in detection skills
South China Morning Post· 3 days ago“Experimental results on human participants demonstrated that this system can perform high-quality...
AmplifyBio and Xcell enter TCR T-cell therapy manufacturing deal
Pharmaceutical Technology via Yahoo Finance· 5 days agoAmplifyBio and Xcell Biosciences have announced a strategic collaboration to advance the...